持股变动声明
Anixa Biosciences(ANIX)05-02 21:25
$Anixa Biosciences(ANIX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-017496 Size: 5 KB 网页链接
简介:Anixa Biosciences, Inc.根据特拉华州法律于1982年11月5日注册成立,是一家生物技术公司,致力于开发针对肿瘤和传染病的关键未满足需求的疗法和疫苗。公司的主要业务是开发嵌合内分泌受体T细胞技术以及发现和最终开发抗癌药物-用于治疗COVID-19的病毒候选药物集中于抑制病毒的某些病毒蛋白功能。
今开:2.47 | 昨收:2.47 |
最高:2.56 | 最低:2.47 |
涨停价: | 跌停价: |
总市值:80656279 |
Anixa Biosciences(ANIX)05-02 21:25
$Anixa Biosciences(ANIX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-017496 Size: 5 KB 网页链接
Anixa Biosciences(ANIX)05-04 01:35
$Anixa Biosciences(ANIX)$ SC 13D General statement of acquisition of beneficial ownership Accession Number: 0001493152-24-017664 Act: 34 Size: 61 KB 网页链接
Anixa Biosciences(ANIX)06-14 22:05
$Anixa Biosciences(ANIX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-023802 Size: 4 KB 网页链接
Anixa Biosciences(ANIX)06-08 00:25
$Anixa Biosciences(ANIX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-023037 Size: 4 KB 网页链接
Anixa Biosciences(ANIX)06-10 22:05
$Anixa Biosciences(ANIX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-023295 Size: 4 KB 网页链接
Anixa Biosciences(ANIX)06-05 05:05
$Anixa Biosciences(ANIX)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001493152-24-022573 Act: 34 Size: 4 MB 网页链接
Anixa Biosciences(ANIX)06-18 21:25
$Anixa Biosciences(ANIX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-024226 Size: 4 KB 网页链接
Anixa Biosciences(ANIX)06-07 23:05
$Anixa Biosciences(ANIX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-023023 Size: 4 KB 网页链接
Anixa Biosciences(ANIX)04-10 21:55
$Anixa Biosciences(ANIX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-014154 Size: 4 KB 网页链接
Anixa Biosciences(ANIX)05-08 20:45
$Anixa Biosciences(ANIX)$ 8-K Current report, items 1.01, 7.01, and 9.01 Accession Number: 0001493152-24-018170 Act: 34 Size: 252 KB 网页链接
andrewmed2021-04-21 09:14
文章来源:“凯莱英药闻”微信公众号
4月19日,纳斯达克上市公司Anixa Biosciences宣布其与莫菲特癌症中心(MCC)共同开发的卵巢癌CAR-T疗法临床试验申请(IND)遭FDA搁置,需补充申请资料以获FDA授权开展临床试验,FDA将在30日给予更详细的答复函。
受此消息影响,Anixa Biosciences股价...查看全文
chuminhua2021-04-20 21:28
4月19日,Anixa Biosciences公司周一宣布,一项评估其卵巢癌CAR-T疗法的临床研究在被FDA要求提供更多信息后被搁置,这一消息使股价下跌了28%。该公司与Moffitt Cancer Center (MCC)共同开发该疗法,并表示已于上个月底提交了IND申请。
该自体细胞疗法是由针对卵泡刺激素(FSH)受体的工程T细胞...查看全文
冷枪手假亦真2020-08-26 00:21
$Anixa Biosciences(ANIX)$ 1.7果断抄底查看全文
LAES1682020-06-27 20:44
$Anixa Biosciences(ANIX)$ 强势,下周过前高查看全文
LAES1682020-06-27 07:43
$Anixa Biosciences(ANIX)$ 盘后刚好破2.81,下周新高可期查看全文
LAES1682020-06-27 03:30
LAES1682020-06-17 03:20
牛唐2020-06-01 22:31
又一个一周50%的收益:$Anixa Biosciences(ANIX)$ 在1.88买入,盘前2.8卖出。 $Zoom Video通讯(ZM)$ $特斯拉(TSLA)$查看全文
chuminhua2019-12-21 15:59
12月13日,据美通社报道:一家致力于利用人体免疫系统来治疗癌症的生物技术公司Anixa Biosciences$Anixa Biosciences(ANIX)$ ,宣布将其FSHR-CAR-T疗法的IND申请延迟12个月,以对该CAR-T疗法进行进一步的基因工程改造,提升其在卵巢癌中的疗效。Anixa公司计划将原定今年底提交的IND申请延迟到2020...查看全文
牛唐2019-07-18 07:50
$Anixa Biosciences(ANIX)$ 爆发13个点,之前 $Evoke Pharma(EVOK)$ 爆发27个点,这行情是看图说话吗查看全文
$Anixa Biosciences(ANIX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-024226 Size: 4 KB 网页链接
$Anixa Biosciences(ANIX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-023802 Size: 4 KB 网页链接
$Anixa Biosciences(ANIX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-023560 Size: 6 KB 网页链接
$Anixa Biosciences(ANIX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-023295 Size: 4 KB 网页链接
$Anixa Biosciences(ANIX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-023037 Size: 4 KB 网页链接
$Anixa Biosciences(ANIX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-023023 Size: 4 KB 网页链接
$Anixa Biosciences(ANIX)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001493152-24-022573 Act: 34 Size: 4 MB 网页链接
$Anixa Biosciences(ANIX)$ 8-K Current report, items 1.01, 7.01, and 9.01 Accession Number: 0001493152-24-018170 Act: 34 Size: 252 KB 网页链接
$Anixa Biosciences(ANIX)$ SC 13D General statement of acquisition of beneficial ownership Accession Number: 0001493152-24-017664 Act: 34 Size: 61 KB 网页链接
$Anixa Biosciences(ANIX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-017496 Size: 5 KB 网页链接